FDA Drug Recalls
220 recalls · Class I, newest first
Class I · High risk Ongoing Sep 18, 2024
Reason Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared dexamethasone and chlorpheniramine.
Class I · High risk Ongoing Aug 1, 2024
Reason Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Class I · High risk Ongoing Jul 24, 2024
Reason Presence of Particulate Matter
Class I · High risk Ongoing Jul 18, 2024
Reason Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
Class I · High risk Ongoing Jul 12, 2024
Reason Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
Class I · High risk Ongoing Jul 12, 2024
Reason Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.
Class I · High risk Ongoing Jul 12, 2024
Reason Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.
Class I · High risk Ongoing Jul 11, 2024
Reason Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.
Class I · High risk Ongoing Jul 8, 2024
Reason Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection…
Class I · High risk Ongoing Jun 25, 2024
Reason Failed Dissolution Specifications
Class I · High risk Ongoing May 30, 2024
Reason Failed Dissolution Specifications
Class I · High risk Ongoing May 30, 2024
Reason Failed Dissolution Specifications
Class I · High risk Ongoing May 28, 2024
Reason Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Class I · High risk Ongoing May 28, 2024
Reason Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Class I · High risk Ongoing May 24, 2024
Reason Microbial Contamination of Non-Sterile Products: Presence of Aspergillus Sydowii (Mold)
Class I · High risk Ongoing Apr 20, 2024
Reason Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
Class I · High risk Ongoing Apr 8, 2024
Reason Sub-potent Drug; powder discoloration associated with decreased potency
Class I · High risk Ongoing Apr 8, 2024
Reason Sub-potent Drug; powder discoloration associated with decreased potency
Class I · High risk Ongoing Mar 23, 2024
Reason Chemical Contamination: Product manufactured with ethanol API that contains methanol
Class I · High risk Ongoing Mar 23, 2024
Reason Chemical Contamination: Product manufactured with ethanol API that contains methanol
Class I · High risk Ongoing Mar 19, 2024
Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Class I · High risk Ongoing Mar 19, 2024
Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Class I · High risk Ongoing Mar 19, 2024
Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Class I · High risk Ongoing Mar 19, 2024
Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Class I · High risk Ongoing Mar 19, 2024
Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.